Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.

Source:http://linkedlifedata.com/resource/pubmed/id/10737480

Download in:

View as

General Info

PMID
10737480